Stockreport

Auris Medical Provides Update on Intranasal Betahistine Programs

Auris Medical Holding AG  (EARS) 
Last auris medical holding ag earnings: 8/10 06:31 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aurismedical.com
PDF Closes acquisition of Orphan Drug Designation for betahistine for the treatment of obesity associated with Prader-Willi syndrome (PWS) Clinical trial applications for [Read more]